Accelerating the Fight Against Cancer
Niowave is an industry-leading supplier of medical radioisotopes, specializing in Actinium-225 (Ac-225) and other isotopes used in targeted cancer therapies. Founded in 2005 as a spinoff from the National Superconducting Cyclotron Lab, the company produces radioisotopes through proprietary superconducting electron linear accelerator technology. Niowave ships cancer treatments from its Lansing, Michigan facilities and addresses supply chain bottlenecks for clinical development and commercialization.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2021
Aug 2019
Jan 2013
Jan 2009
Jan 2008
Aug 2007
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
